Murine models in blood transfusion: Allo-immunization, hemolysis;Modèles murins en transfusion sanguine: Allo-immunisation, hémolyses

Transfusion Clinique et Biologique

Volumn 18, Issue 2, 2011, Pages 115-123

  Desmarets, M ^a   Noizat Pirenne, F ^a  

^a ETABLISSEMENT FRANÇAIS DU SANG   (France)

Author keywords

Allo immunization; Immunehematology; Murine models; Transfusional reactions

Indexed keywords

ERYTHROCYTE ANTIGEN;

ALLOIMMUNIZATION; ANTIBODY RESPONSE; BLOOD TRANSFUSION; BLOOD TRANSFUSION REACTION; DISEASE MODEL; EXPERIMENTAL MOUSE; HEMOLYSIS; NONHUMAN; SHORT SURVEY;

ANEMIA, HEMOLYTIC, AUTOIMMUNE; ANIMALS; BLOOD; BLOOD PRESERVATION; BLOOD PROTEINS; BLOOD TRANSFUSION; ERYTHROCYTES; GENOMICS; HEMOLYSIS; HUMANS; IMMUNIZATION; INFLAMMATION; ISOANTIBODIES; ISOANTIGENS; MICE; MICE, INBRED STRAINS; MICE, TRANSGENIC; MODELS, ANIMAL; SPECIES SPECIFICITY;

EID: 79954632386     PISSN: 12467820     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tracli.2011.01.006     Document Type: Short Survey

References (76)

1. Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S., She X., et al. Lineage-specific biology revealed by a finished genome assembly of the mouse. PLoS Biol 2009, 7:e1000112.
2. Waterston R.H., Lindblad-Toh K., Birney E., Rogers J., Abril J.F., et al. Mouse genome sequencing consortium. Initial sequencing and comparative analysis of the mouse genome. Nature 2002, 420:520-562.
3. Taft R.A., Davisson M., Wiles M.V. Know thy mouse. Trends Genet 2006, 22:649-653.
4. Mestas J., Hughes C.C.W. Of mice and not men: differences between mouse and human immunology. J Immunol 2004, 172:2731-2738.
5. Doeing D.C., Borowicz J.L., Crockett E.T. Gender dimorphism in differential peripheral blood leukocyte counts in mice using cardiac, tail, foot, and saphenous vein puncture methods. BMC Clin Pathol 2003, 3:3.
6. Gessner J.E., Heiken H., Tamm A., Schmidt R.E. The IgG Fc receptor family. Ann Hematol 1998, 76:231-248.
7. Nimmerjahn F., Ravetch J.V. Fcgamma receptors as regulators of immune responses. Nat Rev Immunol 2008, 8:34-47.
8. Rehli M. Of mice and men: species variations of toll-like receptor expression. Trends Immunol 2002, 23:375-378.
9. Ong G.L., Mattes M.J. Mouse strains with typical mammalian levels of complement activity. J Immunol Methods 1989, 125:147-158.
10. Ish C., Ong G.L., Desai N., Mattes M.J. The specificity of alternative complement pathway-mediated lysis of erythrocytes: a survey of complement and target cells from 25 species. Scand J Immunol 1993, 38:113-122.
11. Goodarzi M.O., Lee T.H., Pallavicini M.G., Donegan E.A., Busch M.P. Unusual kinetics of white cell clearance in transfused mice. Transfusion 1995, 35:145-149.
12. Shultz L.D., Ishikawa F., Greiner D.L. Humanized mice in translational biomedical research. Nat Rev Immunol 2007, 7:118-130.
13. Johansson A.C., Sundler M., Kjellén P., Johannesson M., Cook A., Lindqvist A.K., et al. Genetic control of collagen-induced arthritis in a cross with NOD and C57BL/10 mice is dependent on gene regions encoding complement factor 5 and FcgammaRIIb and is not associated with loci controlling diabetes. Eur J Immunol 2001, 31:1847-1856.
14. Churchill G.A., Airey D.C., Allayee H., Angel J.M., Attie A.D., Beatty J., et al. The collaborative cross, a community resource for the genetic analysis of complex traits. Nat Genet 2004, 36:1133-1137.
15. Hod E.A., Arinsburg S.A., Francis R.O., Hendrickson J.E., Zimring J.C., Spitalnik S.L. Use of mouse models to study the mechanisms and consequences of RBC clearance. Vox Sang 2010, 99:99-111.
16. Campbell-Lee S.A., Liu J., Velliquette R.W., Halverson G.R., Shirey R.S., Chaudhuri A., et al. The production of red blood cell alloantibodies in mice transfused with blood from transgenic Fyb-expressing mice. Transfusion 2006, 46:1682-1688.
17. Schirmer D.A., Song S.-C., Baliff J.P., Harbers S.O., Clynes R.A., Krop-Watorek A., et al. Mouse models of IgG- and IgM-mediated hemolysis. Blood 2007, 109:3099-3107.
18. Yu J., Heck S., Yazdanbakhsh K. Prevention of red cell alloimmunization by CD25 regulatory T cells in mouse models. Am J Hematol 2007, 82:691-696.
19. Hartley S.B., Crosbie J., Brink R., Kantor A.B., Basten A., Goodnow C.C. Elimination from peripheral lymphoid tissues of self-reactive B lymphocytes recognizing membrane-bound antigens. Nature 1991, 353:765-769.
20. Hendrickson J.E., Desmarets M., Deshpande S.S., Chadwick T.E., Hillyer C.D., Roback J.D., et al. Recipient inflammation affects the frequency and magnitude of immunization to transfused red blood cells. Transfusion 2006, 46:1526-1536.
21. Zimring J.C., Hair G.A., Chadwick T.E., Deshpande S.S., Anderson K.M., Hillyer C.D., et al. Nonhemolytic antibody-induced loss of erythrocyte surface antigen. Blood 2005, 106:1105-1112.
22. Desmarets M., Cadwell C.M., Peterson K.R., Neades R., Zimring J.C. Minor histocompatibility antigens on transfused leukoreduced units of red blood cells induce bone marrow transplant rejection in a mouse model. Blood 2009, 114:2315-2322.
23. Zimring J.C., Cadwell C.M., Chadwick T.E., Spitalnik S.L., Schirmer D.A., Wu T., et al. Nonhemolytic antigen loss from red blood cells requires cooperative binding of multiple antibodies recognizing different epitopes. Blood 2007, 110:2201-2208.
24. Cadwell C.M., Zimring J.C. Cross-linking induces non-haemolytic antigen-loss from transfused red blood cells: a potential role for rheumatoid factor. Vox Sang 2008, 95:159-162.
25. Zimring J.C., Hendrickson J.E. The role of inflammation in alloimmunization to antigens on transfused red blood cells. Curr Opin Hematol 2008, 15:631-635.
26. Hendrickson J.E., Roback J.D., Hillyer C.D., Easley K.A., Zimring J.C. Discrete toll-like receptor agonists have differential effects on alloimmunization to transfused red blood cells. Transfusion 2008, 48:1869-1877.
27. Hsu L.L., Champion H.C., Campbell-Lee S.A., Bivalacqua T.J., Manci E.A., Diwan B.A., et al. Hemolysis in sickle cell mice causes pulmonary hypertension due to global impairment in nitric oxide bioavailability. Blood 2007, 109:3088-3098.
28. Hod E.A., Cadwell C.M., Liepkalns J.S., Zimring J.C., Sokol S.A., Schirmer D.A., et al. Cytokine storm in a mouse model of IgG-mediated hemolytic transfusion reactions. Blood 2008, 112:891-894.
29. Shinkel T.A., Chen C.G., Salvaris E., Henion T.R., Barlow H., Galili U., et al. Changes in cell surface glycosylation in alpha1,3-galactosyltransferase knockout and alpha1,2-fucosyltransferase transgenic mice. Transplantation 1997, 64:197-204.
30. LaTemple D.C., Galili U. Adult and neonatal anti-Gal response in knock-out mice for alpha1,3galactosyltransferase. Xenotransplantation 1998, 5:191-196.
31. Dawson T.C., Lentsch A.B., Wang Z., Cowhig J.E., Rot A., Maeda N., et al. Exaggerated response to endotoxin in mice lacking the duffy antigen/receptor for chemokines (DARC). Blood 2000, 96:1681-1684.
32. Scott B.B., Sadigh S., Stow M., Mageed R.A., Andrew E.M., Maini R.N. Molecular mechanisms resulting in pathogenic anti-mouse erythrocyte antibodies in New Zealand black mice. Clin Exp Immunol 1993, 93:26-33.
33. Hall A.M., Ward F.J., Shen C.-R., Rowe C., Bowie L., Devine A., et al. Deletion of the dominant autoantigen in NZB mice with autoimmune hemolytic anemia: effects on autoantibody and T-helper responses. Blood 2007, 110:4511-4517.
34. de Sá Oliveira G.G., Izui S., Ravirajan C.T., Mageed R.A., Lydyard P.M., Elson C.J., et al. Diverse antigen specificity of erythrocyte-reactive monoclonal autoantibodies from NZB mice. Clin Exp Immunol 1996, 105:313-320.
35. Jordan M.B., van Rooijen N., Izui S., Kappler J., Marrack P. Liposomal clodronate as a novel agent for treating autoimmune hemolytic anemia in a mouse model. Blood 2003, 101:594-601.
36. Azeredo da Silveira S., Kikuchi S., Fossati-Jimack L., Moll T., Saito T., Verbeek J.S., et al. Complement activation selectively potentiates the pathogenicity of the IgG2b and IgG3 isotypes of a high affinity anti-erythrocyte autoantibody. J Exp Med 2002, 195:665-672.
37. Sylvestre D., Clynes R., Ma M., Warren H., Carroll M.C., Ravetch J.V. Immunoglobulin G-mediated inflammatory responses develop normally in complement-deficient mice. J Exp Med 1996, 184:2385-2392.
38. Kumar V., Ali S.R., Konrad S., Zwirner J., Verbeek J.S., Schmidt R.E., et al. Cell-derived anaphylatoxins as key mediators of antibody-dependent type II autoimmunity in mice. J Clin Invest 2006, 116:512-520.
39. Molina H., Miwa T., Zhou L., Hilliard B., Mastellos D., Maldonado M.A., et al. Complement-mediated clearance of erythrocytes: mechanism and delineation of the regulatory roles of Crry and DAF decay-accelerating factor. Blood 2002, 100:4544-4549.
40. Nimmerjahn F., Ravetch J.V. Fcgamma receptors: old friends and new family members. Immunity 2006, 24:19-28.
41. Sadlack B., Löhler J., Schorle H., Klebb G., Haber H., Sickel E., et al. Generalized autoimmune disease in interleukin-2-deficient mice is triggered by an uncontrolled activation and proliferation of CD4+ T cells. Eur J Immunol 1995, 25:3053-3059.
42. Hoyer K.K., Kuswanto W.F., Gallo E., Abbas A.K. Distinct roles of helper T-cell subsets in a systemic autoimmune disease. Blood 2009, 113:389-395.
43. Playfair J.H., Marshall-Clarke S. Induction of red cell autoantibodies in normal mice. Nature New Biol 1973, 243:213-214.
44. Mqadmi A., Zheng X., Yazdanbakhsh K. CD4+CD25+ regulatory T cells control induction of autoimmune hemolytic anemia. Blood 2005, 105:3746-3748.
45. Cooke L.A., Staines N.A., Morgan A., Moorhouse C., Harris G. Haemolytic disease in mice induced by transplantation of hybridoma cells secreting monoclonal anti-erythrocyte autoantibodies. Immunology 1982, 47:569-572.
46. Sharon R., Naor D. Experimental model of autoimmune hemolytic anemia induced in mice with levodopa. Clin Immunol Immunopathol 1989, 52:160-172.
47. Okamoto M., Murakami M., Shimizu A., Ozaki S., Tsubata T., Kumagai S., et al. A transgenic model of autoimmune hemolytic anemia. J Exp Med 1992, 175:71-79.
48. Murakami M., Nakajima K., Yamazaki K., Muraguchi T., Serikawa T., Honjo T. Effects of breeding environments on generation and activation of autoreactive B-1 cells in anti-red blood cell autoantibody transgenic mice. J Exp Med 1997, 185:791-794.
49. Horn S., Bashan N., Gopas J. Phagocytosis of phenylhydrazine oxidized and G-6-PD-deficient red blood cells: the role of cell-bound immunoglobulins. Blood 1991, 78:1818-1825.
50. Spolarics Z., Condon M.R., Siddiqi M., Machiedo G.W., Deitch E.A. Red blood cell dysfunction in septic glucose-6-phosphate dehydrogenase-deficient mice. Am J Physiol Heart Circ Physiol 2004, 286:H2118-H2126.
51. Adachi H. Pathological study on experimental Heinz body anemia: intracellular changes of phagocytized red cells in macrophages of the spleen and liver. Acta Pathol Jpn 1977, 27:657-675.
52. Terpstra V., van Berkel T.J. Scavenger receptors on liver Kupffer cells mediate the in vivo uptake of oxidatively damaged red blood cells in mice. Blood 2000, 95:2157-2163.
53. Ganick D.J., Segel G.B., Chamberlain J., Hirsch L., Klemperer M.R. The effects of splenectomy and glucocorticoids on survival and hepatic uptake of damaged red cells in the mouse. Am J Hematol 1977, 2:365-373.
54. Jain S.K., Mohandas N., Clark M.R., Shohet S.B. The effect of malonyldialdehyde, a product of lipid peroxidation, on the deformability, dehydration and 51Cr-survival of erythrocytes. Br J Haematol 1983, 53:247-255.
55. Lang K.S., Lang P.A., Bauer C., Duranton C., Wieder T., Huber S.M., et al. Mechanisms of suicidal erythrocyte death. Cell Physiol Biochem 2005, 15:195-202.
56. Wu Y., Tibrewal N., Birge R.B. Phosphatidylserine recognition by phagocytes: a view to a kill. Trends Cell Biol 2006, 16:189-197.
57. Boas F.E., Forman L., Beutler E. Phosphatidylserine exposure and red cell viability in red cell aging and in hemolytic anemia. Proc Natl Acad Sci USA 1998, 95:3077-3081.
58. Schroit A.J., Madsen J.W., Tanaka Y. In vivo recognition and clearance of red blood cells containing phosphatidylserine in their plasma membranes. J Biol Chem 1985, 260:5131-5138.
59. Lang F., Gulbins E., Lang P.A., Zappulla D., Föller M. Ceramide in suicidal death of erythrocytes. Cell Physiol Biochem 2010, 26:21-28.
60. Banerjee T., Kuypers F.A. Reactive oxygen species and phosphatidylserine externalization in murine sickle red cells. Br J Haematol 2004, 124:391-402.
61. De Jong K., Emerson R.K., Butler J., Bastacky J., Mohandas N., Kuypers F.A. Short survival of phosphatidylserine-exposing red blood cells in murine sickle cell anemia. Blood 2001, 98:1577-1584.
62. Chadebech P., Habibi A., Nzouakou R., Bachir D., Meunier-Costes N., Bonin P., et al. Delayed hemolytic transfusion reaction in sickle cell disease patients: evidence of an emerging syndrome with suicidal red blood cell death. Transfusion 2009, 49:1785-1792.
63. Kempe D.S., Lang P.A., Duranton C., Akel A., Lang K.S., Huber S.M., et al. Enhanced programmed cell death of iron-deficient erythrocytes. FASEB J 2006, 20:368-370.
64. Oldenborg P.A., Zheleznyak A., Fang Y.F., Lagenaur C.F., Gresham H.D., Lindberg F.P. Role of CD47 as a marker of self on red blood cells. Science 2000, 288:2051-2054.
65. Olsson M., Nilsson A., Oldenborg P.A. Dose-dependent inhibitory effect of CD47 in macrophage uptake of IgG-opsonized murine erythrocytes. Biochem Biophys Res Commun 2007, 352:193-197.
66. Subramanian S., Tsai R., Sen S., Dahl K.N., Discher D.E. Membrane mobility and clustering of integrin associated protein (IAP CD47)-major differences between mouse and man and implications for signaling. Blood Cells Mol Dis 2006, 36:364-372.
67. Mouro-Chanteloup I., Delaunay J., Gane P., Nicolas V., Johansen M., Brown E.J., et al. Evidence that the red cell skeleton protein 4.2 interacts with the Rh membrane complex member CD47. Blood 2003, 101:338-344.
68. Gilson CR, Kraus T, Hod E, Hendrickson JE, Spitalnik S, Hillyer C, et al. A novel mouse model of red blood cell storage and posttransfusion in vivo survival. Transfusion 2009 x.[sous presse]. doi:10.1111/j.1537-2995.2009.02173.
69. Makley A.T., Goodman M.D., Friend L.A.W., Johannigman J.A., Dorlac W.C., Lentsch A.B., et al. Murine blood banking: characterization and comparisons to human blood. Shock 2010, 34:40-45.
70. Hod E.A., Zhang N., Sokol S.A., Wojczyk B.S., Francis R.O., Ansaldi D., et al. Transfusion of red blood cells after prolonged storage produces harmful effects that are mediated by iron and inflammation. Blood 2010, 115:4284-4292.
71. Hendrickson J., Hod E., Spitalnik S., Hillyer C., Zimring J. Storage of murine red blood cells enhances alloantibody responses to an erythroid-specific model antigen. Transfusion 2010, 50:642-648.
72. Hendrickson J.E., Hod E.A., Cadwell C.M., Eisenbarth S.C., Spiegel D.A., Tormey C.A., et al. The effects of rapid RBC clearance and post-transfusion cytokine storm on alloimmunization in a murine model. Transfusion 2010, 50:16A-17A.
73. Zimring J.C., Cadwell C.M., Spitalnik S.L. Antigen loss from antibody-coated red blood cells. Transfus Med Rev 2009, 23:189-204.
74. Auffray I., Marfatia S., de Jong K., Lee G., Huang C.H., Paszty C., et al. Glycophorin A dimerization and band 3 interaction during erythroid membrane biogenesis: in vivo studies in human glycophorin A transgenic mice. Blood 2001, 97:2872-2878.
75. Bao W., Yu J., Heck S., Yazdanbakhsh K. Regulatory T-cell status in red cell alloimmunized responder and nonresponder mice. Blood 2009, 113:5624-5627.
76. Hendrickson JE, Saakadze N, Cadwell CM, Upton J, Mocarski E, Hillyer C, et al. The spleen plays a central role in primary humoral alloimmunization to transfused mHEL red blood cells. Transfusion 2009; x.[sous presse]. doi:10.1111/j.1537-2995.2009.02200.